Omega-3 fatty acids for depression in adults
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of n3 polyunsaturated fatty acids (n3PUFAs) (also known as omega‐3 fatty acids) compared with comparator (e.g. placebo, anti‐depressant treatment, standard care, no treatment, wait‐list control) for major depressive disorder in adults.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.